1. World Health Organization: Global tuberculosis control 2008: surveillance, planning, financing. 2008, Geneva: WHO
2. Albert H: Economic analysis of the diagnosis of smear-negative pulmonary tuberculosis in South Africa: incorporation of a new rapid test, FASTPlaqueTB, into the diagnostic algorithm. Int J Tuberc Lung Dis. 2004, 8: 240-247.
3. Suarez PG, Floyd K, Portocarrero J, Alarcon E, Rapiti E, Ramos G, et al: Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet. 2002, 359: 1980-1989. 10.1016/S0140-6736(02)08830-X.
4. van Cleeff M, Kivihya-Ndugga L, Githui W, Ng'ang'a L, Kibuga D, Odhiambo J, et al: Cost-effectiveness of polymerase chain reaction versus Ziehl-Neelsen smear microscopy for diagnosis of tuberculosis in Kenya. Int J Tuberc Lung Dis. 2005, 9: 877-883.
5. Keeler E, Perkins MD, Small P, Hanson C, Reed S, Cunningham J, et al: Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature. 2006, 444 (Suppl 1): 49-57. 10.1038/nature05446.